A detailed history of Founders Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Founders Capital Management, LLC holds 24,047 shares of JNJ stock, worth $3.96 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
24,047
Previous 24,198 0.62%
Holding current value
$3.96 Million
Previous $3.83 Million 8.18%
% of portfolio
0.64%
Previous 0.71%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$144.38 - $157.78 $21,801 - $23,824
-151 Reduced 0.62%
24,047 $3.51 Million
Q1 2024

Apr 22, 2024

SELL
$155.22 - $162.74 $103,376 - $108,384
-666 Reduced 2.68%
24,198 $3.83 Million
Q4 2023

Jan 23, 2024

SELL
$145.6 - $158.88 $29,556 - $32,252
-203 Reduced 0.81%
24,864 $3.9 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $36,757 - $41,177
-236 Reduced 0.93%
25,067 $3.9 Million
Q2 2023

Jul 26, 2023

SELL
$154.35 - $166.11 $62,048 - $66,776
-402 Reduced 1.56%
25,303 $4.19 Million
Q1 2023

Apr 18, 2023

SELL
$151.05 - $180.26 $69,331 - $82,739
-459 Reduced 1.75%
25,705 $3.98 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $55,749 - $62,566
-348 Reduced 1.31%
26,164 $0
Q3 2022

Oct 21, 2022

SELL
$161.33 - $179.52 $27,103 - $30,159
-168 Reduced 0.63%
26,512 $4.33 Million
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $65,490 - $72,664
-420 Reduced 1.55%
26,680 $4.56 Million
Q3 2021

Oct 21, 2021

SELL
$161.5 - $179.47 $81,073 - $90,093
-502 Reduced 1.82%
27,100 $4.38 Million
Q2 2021

Jul 15, 2021

BUY
$159.48 - $171.07 $11,163 - $11,974
70 Added 0.25%
27,602 $4.55 Million
Q4 2020

Jan 15, 2021

SELL
$137.11 - $157.38 $46,617 - $53,509
-340 Reduced 1.22%
27,532 $4.33 Million
Q3 2020

Oct 19, 2020

SELL
$140.38 - $153.83 $181,090 - $198,440
-1,290 Reduced 4.42%
27,872 $4.15 Million
Q1 2020

Apr 20, 2020

BUY
$111.14 - $153.99 $81,354 - $112,720
732 Added 2.57%
29,162 $3.82 Million
Q3 2019

Oct 09, 2019

SELL
$126.95 - $142.14 $26,532 - $29,707
-209 Reduced 0.73%
28,430 $3.8 Million
Q2 2019

Jul 11, 2019

BUY
$131.15 - $144.24 $43,804 - $48,176
334 Added 1.18%
28,639 $3.99 Million
Q1 2019

Apr 16, 2019

SELL
$125.72 - $139.79 $12,572 - $13,979
-100 Reduced 0.35%
28,305 $3.96 Million
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $447,506 - $538,581
-3,643 Reduced 11.37%
28,405 $3.67 Million
Q3 2018

Oct 11, 2018

SELL
$121.58 - $142.88 $2.84 Million - $3.34 Million
-23,355 Reduced 42.15%
32,048 $4.46 Million
Q2 2018

Jul 09, 2018

BUY
$119.4 - $131.76 $2,985 - $3,294
25 Added 0.05%
55,403 $6.72 Million
Q1 2018

Apr 04, 2018

SELL
$125.1 - $148.14 $59,047 - $69,922
-472 Reduced 0.85%
55,378 $6.9 Million
Q4 2017

Jan 10, 2018

SELL
$131.22 - $143.62 $21,913 - $23,984
-167 Reduced 0.3%
55,850 $7.8 Million
Q3 2017

Oct 16, 2017

BUY
$129.47 - $135.38 $7.25 Million - $7.58 Million
56,017
56,017 $7.28 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Founders Capital Management, LLC Portfolio

Follow Founders Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.